Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical has applied to the ASX for quotation of 2,000,000 additional ordinary fully paid shares, issued on 13 February 2026 following the exercise of options or conversion of other securities. The move modestly increases the company’s free float and share capital, potentially enhancing liquidity in its stock while signalling ongoing utilisation of equity-based instruments in its capital structure.
The most recent analyst rating on (AU:4DX) stock is a Sell with a A$3.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian-listed company in the medical technology sector, trading on the ASX under the ticker 4DX. The company is involved in developing and commercialising advanced imaging or diagnostic solutions, with its ordinary fully paid shares representing its primary listed security for investors on the exchange.
Average Trading Volume: 6,259,052
Technical Sentiment Signal: Buy
Current Market Cap: A$2.14B
See more data about 4DX stock on TipRanks’ Stock Analysis page.